![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, November 18, 2008 3:21:16 PM
PL1, Thanks for posting yet another interesting and relevant article. It appears, increasingly, there is an enormous amount of important progress to be made, in Pharmacogenomics (also known as Personalized Medicine/Theranostics.) I'm glad that DNAPrint Genomics is one of a handful of companies, that is pioneering this field.
P.S., I currently own 198,411,787 shares of DNAG. (15.3% of outstanding shares.)
![smile](/images/emoticon01.gif)
Daniel Gannon
Portland, Oregon, USA
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM